Wolverine Asset Management LLC Inovio Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Asset Management LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 08, 2023	SELL	$0.79 - $1.91 $79,000 - $191,000	-100,000 Reduced 99.7%	300 $0
Q1 2022 May 04, 2022	SELL	$2.97 - $5.2 $37,719 - $66,040	-12,700 Reduced 11.24%	100,300 $360,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $676,620 - $915,705	94,500 Added 510.81%	113,000 $809,000
Q1 2021 May 13, 2021	BUY	$8.81 - $16.96 $48,455 - $93,280	5,500 Added 42.31%	18,500 $171,000
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $100,300 - $151,630	11,800 Added 983.33%	13,000 $115,000
Q3 2020 Nov 13, 2020	SELL	$9.57 - $27.05 $128,238 - $362,470	-13,400 Reduced 91.78%	1,200 $13,000
Q2 2020 Aug 13, 2020	SELL	$7.14 - $31.69 $12,852 - $57,042	-1,800 Reduced 10.98%	14,600 $393,000
Q1 2020 May 13, 2020	SELL	$2.98 - $14.09 $5,960 - $28,180	-2,000 Reduced 10.87%	16,400 $122,000
Q4 2019 Feb 14, 2020	BUY	$1.97 - $3.72 $22,064 - $41,664	11,200 Added 155.56%	18,400 $60,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $54,939 - $80,936	-26,800 Reduced 78.82%	7,200 $14,000
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $113,560 - $173,400	34,000 New	34,000 $126,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $566M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.